QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 viemed-healthcare-narrows-fy2025-sales-guidance-from-271000m-277000m-to-271000m-273000m-vs-267050m-est

Viemed Healthcare (NASDAQ:VMD) narrows FY2025 sales outlook from $271.000 million-$277.000 million to $271.000 million-$273.000...

 viemed-healthcare-q3-eps-009-inline-sales-71914m-miss-72000m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is...

Core News & Articles

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

 viemed-healthcare-raises-fy2025-sales-guidance-from-256000m-265000m-to-271000m-277000m-vs-260550m-est

Viemed Healthcare (NASDAQ:VMD) raises FY2025 sales outlook from $256.000 million-$265.000 million to $271.000 million-$277.000 ...

 viemed-healthcare-q2-eps-008-inline-sales-63056m-miss-63100m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. This is...

 viemed-healthcare-raises-fy2025-sales-guidance-from-25400m-26500m-to-25600m-26500m-vs-26000m-est

Viemed Healthcare (NASDAQ:VMD) raises FY2025 sales outlook from $254.00 million-$265.00 million to $256.00 million-$265.00 mill...

 viemed-healthcare-q1-eps-006-inline-sales-5913m-miss-6060m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is...

 viemed-healthcare-agrees-to-acquire-lehans-medical-equipment-for-base-purchase-price-of-26m

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acu...

 viemed-healthcare-expects-fy25-net-revenue-of-254m--265m-est-25150m

Adjusted EBITDA for the year ending December 31, 2025 is expected to be in the range of $54 million to $58 million.

 viemed-healthcare-q4-2024-gaap-eps-010-inline-sales-6070m-beat-5995m-estimate

Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. This is...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION